在国际科技竞争日趋激烈、产业链安全与国家安全深度交织的背景下，专精特新企业作为强化产业链韧性、解决"卡脖子"难题的中坚力量，其培育与发展成 为北京建设国际科技创新中心的关键抓手。 北京市"十五五"规划建议稿明确提出培育壮大科技领军企业，加强高新技术企业和科技型中小企业支持，培育独角兽企业、专精特新"小巨人"企业。今年北 京两会期间，人大代表们也针对科技企业上市瓶颈、基金支持导向、培育生态构建等关键问题建言献策，为专精特新企业爬坡过坎开出"药方"。 市人大代表、德勤中国华北区政府事务负责人马飞骏建议，提出全面构建专精特新企业培育生态；市人大代表、北京柏睿数据技术股份有限公司董事梁雪青 则聚焦高精尖产业发展基金如何优先支持数智基础设施类国家专精特新"小巨人"企业。两位代表的建议直指当前科技企业在成长过程中面临的资金周期错配 等问题，为保障企业更好发展和产业生态良性循环提供了参考意见。 市人大代表、德勤中国华北区政府事务负责人马飞骏。受访者供图 让"专精特新"与"小巨人"企业跳出资本瓶颈 截至2025年底，北京市累计认定专精特新企业11062家，国家级专精特新"小巨人"企业1214家，A股上市专精特新企业172家， ...

Core Viewpoint - A total of 3,482 enterprises across various provinces and cities in China have been selected as the latest batch of "specialized, refined, and innovative" small giant enterprises, highlighting the growth and innovation in the instrumentation sector [1]. Summary by Sections Instrumentation Companies in Beijing - Notable companies include Beijing Hexie Navigation Technology Co., Ltd., specializing in military Beidou fiber optic positioning receivers, and Beijing Zhongke Feilong Sensor Technology Co., Ltd., which focuses on advanced sensors for various applications [1]. - Other companies like Beijing Huaneng New Forging Technology Co., Ltd. and Beijing Simo Intelligent Technology Co., Ltd. are involved in smart manufacturing and AI vision detection systems [1]. Instrumentation Companies in Shanghai - Shanghai-based companies such as Shanghai Langshan Sensor Technology Co., Ltd. and Shanghai Yinuo Instrument Co., Ltd. are engaged in various sensor technologies, including high-temperature MEMS chips and online gas chromatography [2][3]. - Companies like Shanghai Anpu Experimental Technology Co., Ltd. focus on laboratory consumables, while Shanghai Hedi Electronic Technology Co., Ltd. specializes in optical measurement devices [2]. Instrumentation Companies in Jiangsu - Jiangsu province features companies like Wuxi Beimi Sensor Technology Co., Ltd., which develops tilt sensors and inertial navigation systems, and Suzhou Nanzhi Sensor Technology Co., Ltd., focusing on distributed optical fiber sensors [4]. - Other notable firms include Changzhou Changxing Detection Technology Co., Ltd., which provides testing equipment and consumables [4]. Instrumentation Companies in Guangdong - Guangdong province hosts companies such as Guangzhou Deqing Optical Technology Co., Ltd., which specializes in laser welding defect detection systems, and Guangzhou Han Guang Electric Co., Ltd., focusing on smart energy management systems [5]. - Companies like Dongguan Crystal Optical Co., Ltd. are involved in optical molds and lenses [5]. Instrumentation Companies in Other Provinces - Companies in provinces like Anhui and Zhejiang are also recognized, with firms like Hefei Xieli Instrument Control Technology Co., Ltd. focusing on intelligent vehicle instruments and Hangzhou Puan Technology Co., Ltd. producing energy metering devices [6][7]. - In Henan, Henan Hongbo Measurement and Control Technology Co., Ltd. is noted for its online monitoring systems and testing instruments [8].

| 项目 | 2025年1月-6月 | | 2024 年度 | 2023 年度 | | 2022 年度 | | | --- | --- | --- | --- | --- | --- | --- | --- | | | 金额 比例 | | 金额 | 比例 金額 | 比例 | 金额 | 比例 | | 热流道系统 | 14,051.87 | 96.00% 22,588.47 | | 96.84% 16,301.84 | 97.03% 13,718.30 | | 96.41% | | 其他 | 584.84 | 4.00% | 737.26 | 498.38 3.16% | 2.97% | 511.38 | 3.59% | | 合计 | | | | 14,636.72 100.00% 23,325.73 100.00% 16,800.22 100.00% 14,229.68 00.00% | | | | 公司前身有限公司成立于2010年10月，2023年8月整体变更为股份有限公司，2024年12月30日挂牌 新三板，证券代码874202。公司目前注册资本3924万元。公司控股股东、实际控制人为1974 年出生 的王 ...

Core Insights - Hangzhou's export scale reached 646.7 billion yuan in 2025, marking an 8.7% year-on-year increase, ranking eighth among cities in China, up one position from 2024 [1] - The total foreign trade import and export value for Hangzhou in 2025 was 906.95 billion yuan, a growth of 6.1%, accounting for 16.4% of the province's total foreign trade [1] Group 1: Export Growth Drivers - The rise in rankings is attributed to the expansion into emerging markets, optimization of product structure, and strong growth in cross-border e-commerce [2] - Exports to major emerging markets showed consistent growth, with exports to Latin America, the Middle East, and Africa reaching 61.46 billion yuan, 50.73 billion yuan, and 33.92 billion yuan respectively, with growth rates of 11.2%, 15.1%, and 17.9% [2] - Exports to BRICS countries and partner nations totaled 177.73 billion yuan, growing by 9.0%, while exports to Belt and Road Initiative countries reached 320.72 billion yuan, increasing by 14.1% [2] Group 2: High-tech Product Exports - High-tech product exports from Hangzhou amounted to 100.11 billion yuan, growing by 9.9%, which is 1.2 percentage points higher than the overall city export growth rate, representing 15.5% of total exports and 30.7% of the province's high-tech product exports [2] - The "new three items" (electric vehicles, lithium-ion batteries, and photovoltaic products) saw exports of 25.57 billion yuan, a significant increase of 49.9% [2] Group 3: Cross-border E-commerce Growth - In 2025, exports through the cross-border e-commerce platform reached 75.87 billion yuan, a growth of 30.6%, contributing 3.0 percentage points to the city's export growth, exceeding the provincial growth rate by 5.6 percentage points, and accounting for 28.3% of the province's total cross-border exports [3] - The logistics sector reflected this growth, with Hangzhou's air port handling over 20.9 million cross-border e-commerce shipments, with a cargo volume of 154.5 thousand tons, making up 70% of the total export cargo volume [3] Group 4: Increase in Export Enterprises - The number of enterprises engaged in import and export activities in Hangzhou reached 20,425, an increase of 2,276 year-on-year, with 16,417 of these being private enterprises, which exported 497.98 billion yuan, growing by 11.3% [3] - Notably, specialized and innovative enterprises performed exceptionally well, with 271 national-level "little giant" enterprises exporting 32.6 billion yuan, a growth of 26.7% [3]

金山君这日浏览北交所网站，忽然发现有一家公司来自海南儋州——这可不得了，首先，儋州是俺偶像苏东坡流放过的地方，其次，根据海南证监局官方 数据，目前A股注册地在海南的上市公司一共也就有27家，且在北交所上市的数量至今为：0。 众所周知，IPO市场上，长三角和珠三角历来是上市公司热门产地。 官网上，则有一套时间线略对不上的说明： 也就是说，这家延安医药，一旦上市成功，将为海南省和儋州市实现北交所零的突破，可谓意义非凡。 怀着强烈的好奇心，金山君立刻点开细看，结果发现，这家公司的全名居然是上海延安医药洋浦股份有限公司。虽说27家海南上市公司里、也有5家是异 地办公的，但明晃晃地在公司名字里带着不一样地名的，这还是独一份。 更何况，延安医药还要在自家官网上强调与上海的密切渊源："上海延安药业前身为中法大药房，由上海民族实业家黄楚九先生于一八九O年创建"。还真 是地方扶持和老店名声，什么都要呀，吃相不一般的。 看看企查查的历史变更记录，2004年，公司在字面上从海南搬到了上海： | 上海延安万象药业有限公司被海南信谊医药有限公司收购，转制更名为"上海延安药业有限公司"。海南信谊医药有限公司更名为上海延安医药洋浦有限公司 ...

Core Viewpoint - The recent upward trend in the net value curve of the CSI 2000 Enhanced ETF (159552) indicates a market-driven style shift, with investors recognizing a wave of capital inflow [1] Group 1: Market Trends - Historical data shows that each significant increase in trading volume is accompanied by a strong rise in small-cap stocks, with the CSI 2000 outperforming the CSI 300 by 196% during the 2014-2015 market surge [2] - Since January, the average daily trading volume of A-shares has stabilized above 2.5 trillion, signaling the start of a new style rotation [3] Group 2: Performance and Strategy - Past trends indicate that small-cap outperformance typically lasts 2-3 months following a breakthrough in trading volume, suggesting potential for continuation in the current cycle [5] - The current macroeconomic environment, characterized by loose monetary policy and supportive policies for emerging industries, provides a solid foundation for the continuation of small-cap performance [5] - The CSI 2000 Enhanced ETF serves as an effective tool to capture this historical opportunity, tracking the CSI 2000 index closely and benefiting from liquidity premiums, with an annualized excess return of 19.87% since inception [5] Group 3: Future Outlook - The ongoing macro liquidity supports small-cap stocks, while emerging industry transformations open growth opportunities for small enterprises, particularly in dynamic sectors like AI and high-end manufacturing [6] - The CSI 1000 Enhanced ETF (159680) has also shown strength recently, with an annualized excess return of 10.49%, allowing investors to build a "high elasticity + stable growth" small-cap portfolio based on their risk preferences [6]

出口跨境电商货物连夜装机。 杭州外贸出口规模排名实现新突破。据钱江海关统计，2025年杭州（含省级公司，下同）出口6467 亿元，同比增长8.7%，在全国城市中出口规模排名居第八位，较2024年上升一位。 出口的增长为杭州全年外贸进出口增长提供了关键支撑。2025年，杭州外贸进出口总值9069.5亿 元，增长6.1%，占全省外贸进出口总值的16.4%。 排名晋升的背后，是新兴市场开拓、产品结构优化与跨境电商等新动能的强劲驱动。 2025年，杭州对主要新兴市场出口均保持增长。其中，对拉美、中东、非洲分别出口614.6亿元、 507.3亿元、339.2亿元，增长11.2%、15.1%、17.9%，增速均高于全省。同期，杭州对金砖成员国及伙 伴国出口1777.3亿元，增长9.0%；对共建"一带一路"国家出口3207.2亿元，增长14.1%。 2025年，杭州高新技术产品出口1001.1亿元，增长9.9%，领先全市出口增速1.2个百分点，占全市 出口15.5%，占全省高新技术产品出口的30.7%。其中，电动汽车、锂离子蓄电池、光伏产品等"新三 样"产品出口255.7亿元，增长49.9%。 新业态方面，2025年杭州通 ...

Market Overview - The market experienced a mild increase this week, with the average daily trading volume in the Shanghai and Shenzhen markets significantly declining, yet remaining at a historical high of approximately 2.7 trillion [1][3] - A-shares have escaped short-term emotional fluctuations and returned to a rational operational track, supporting a steady and gradual bull market trend [1][3] - Market activity remains high, indicating numerous investment opportunities [1][3] Investment Strategy - The company anticipates that the market will exhibit a "slow bull" characteristic until the Chinese New Year, with rapid theme rotations [1][3] - A long-term investment strategy is recommended, focusing on selecting stocks with favorable long-term trends while avoiding short-term speculation [1][3] Long-term Focus Areas 1. The repeated TACO (Trade Adjustment and Cooperation Agreement) by the U.S. may lead countries to accelerate self-sufficiency in defense, resources, finance, and supply chains, intensifying resource competition and indicating an upward cycle for commodities [1][3] 2. The intensifying global technology competition is driving the domestic strategy for technological self-reliance, presenting dual development opportunities in the A-share technology growth sector through domestic substitution and industrial upgrading [1][3] Industry Performance - In the past week, the construction materials, oil and petrochemicals, and steel industries performed notably well, with respective increases of +9.23%, +7.71%, and +7.31% [14]

Core Viewpoint - Yongxin Zhicheng experienced a decline of 5.51% on January 26, with a trading volume of 101 million yuan, indicating potential market volatility and investor sentiment concerns [1]. Financing Summary - On January 26, Yongxin Zhicheng had a financing buy amount of 11.48 million yuan and a financing repayment of 11.99 million yuan, resulting in a net financing buy of -0.51 million yuan [1]. - The total financing and margin trading balance for Yongxin Zhicheng reached 136 million yuan, accounting for 3.77% of its market capitalization, which is above the 60th percentile of the past year [1]. - The company had a margin balance of 271,000 yuan with a margin volume of 11,400 shares, exceeding the 90th percentile of the past year, indicating a high level of short selling activity [1]. Business Performance - As of September 30, Yongxin Zhicheng reported a total revenue of 142 million yuan for the first nine months of 2025, reflecting a year-on-year decrease of 17.72% [2]. - The company recorded a net profit attributable to shareholders of -54.85 million yuan, a significant decline of 73.68% compared to the previous year [2]. Shareholder Information - As of September 30, 2025, Yongxin Zhicheng had 6,011 shareholders, a decrease of 0.96% from the previous period, while the average number of circulating shares per shareholder increased by 0.96% to 12,126 shares [2]. - The company has distributed a total of 36.03 million yuan in dividends since its A-share listing [3]. - Notably, two funds, Bosera Military Industry Theme Stock A and Bosera Emerging Growth Mixed, have exited the list of the top ten circulating shareholders [3].

中证报中证网讯(记者张鹏飞)近日，浙江省经济和信息化厅公布2025年度省级"专精特新"中小企业名 单，步长制药（603858）旗下浙江天元生物药业有限公司凭借在生物制药领域的"专精特新"发展优势成 功入选，标志着其核心竞争力获得权威认可。 作为步长制药在生物药、疫苗领域的战略核心载体，浙江天元生物药业深耕生物制药细分赛道，持续构 建差异化竞争优势，此次入选是其坚守"专精特新"发展路径、深耕细作的必然成果。 精细化管理上，公司严格遵循医药行业高标准规范，建立覆盖研发、生产、仓储、流通全流程的质量管 控体系，近三年无重大安全质量事故，以规范稳健的经营表现顺利通过各项审核。 此次获评省级"专精特新"企业，印证了步长制药多元产业生态布局的战略优势。未来，天元生物将借力 政策红利，进一步加大研发投入力度，聚焦生物药与疫苗领域的技术创新与产品迭代，持续提升核心竞 争力，为区域健康产业高质量发展注入新动能。 专业化布局上，公司聚焦疫苗与生物制品的研发、生产与转化，核心产品精准对接重大疾病防治临床需 求，多款重点项目已顺利进入临床试验阶段。 创新能力建设上，依托步长制药研发投入支撑，天元生物构建了完善的自主创新体系，研发费用 ...